Loss of Fanconi anemia (FA) proteins activity by recessive inherited mutations in one of the FA genes leads to a disease characterized by bone marrow failure, myeloid leukemia and DNA damage hypersensitivity. The aim of this work was to improve our understanding of the FA syndrome defining the transcription profile of the FA complementation group C (FANCC)-deficient cells in comparison to their ectopically corrected counterpart using oligonucleotide microarrays. In this way, 49 RNAs have been isolated, which showed a consistent differential pattern of expression among FANCC mutated and corrected cells. The observed specific changes in gene expression suggest that FANCC regulates specifically myeloid differentiation and unmasks a previously unsuspected anti-inflammatory role for the FA proteins. In spite of the DNA damage hypersensitivity of the syndrome, no gene coding for a protein directly involved in DNA repair/ damage response was found to be deregulated in our analysis. This observation suggests that FANCC does not directly control genes involved in DNA repair at the transcriptional level, but does not exclude a regulation at the translational or post-translational level, or by protein/ protein interactions. The potential role of the differentially expressed genes in FA phenotype as well as a functional-and cellular-based clustering of the identified genes are presented and discussed.
Introduction
Fanconi anemia (FA) is a rare genetic recessive syndrome featuring bone marrow failure, cancer predisposition and DNA damage hypersensitivity. The invariable clinical trait is a progressive aplastic anemia leading to pancytopenia (Grompe and D'Andrea, 2001; Joenje and Patel, 2001; Ahmad et al., 2002) . FA patients have an increased risk of acute myeloid leukemia (AML) (Alter, 1996) and alterations in FA genes have been associated to sporadic AML (Xie et al., 2000) . Cells from FA patients demonstrate chromosomal fragility and hypersensitivity to DNA cross-linking agents, such as mitomycin C (MMC) or photoactivated psoralens, suggesting a defect in DNA repair mechanisms (Grompe and D'Andrea, 2001) . Two other general features have been associated with the FA phenotype: an altered redox status of the cell (Ahmad et al., 2002) and a tumor necrosis factor a (TNF-a) overproduction (Schultz and Shahidi, 1993; Rosselli et al., 1994) . However, the causal relationship between these anomalies and the FA molecular defect remains unclear. Eight responsible genes, FANCA, FANCC, FANCD1/BRCA2, FANCD2, FANCE, FANCF, FANCG/XRCC9 and FANCL, have been cloned. They have little, if any homology to each other. FA proteins may assemble in complex(es) that appear(s) to cooperate in common cellular pathways (D'Andrea and Grompe, 2003) . The pleiotropic characteristics of the FA syndrome suggest that FA gene products are involved in the control of the cellular homeostasis, a key function in DNA damaging agent response and differentiation.
To improve our understanding of the syndrome, we decided to quantify changes in gene expression comparing FA-C cells to their FANCC corrected counterpart using oligonucleotide microarrays. In this way, 49 RNAs have been isolated, which showed a consistent differential pattern of expression between FA-C and FA-C corrected cells. Semiquantitative RT-PCR, quantitative (real-time) PCR or functional analysis validated the obtained data. Although several of the identified genes do not have an obvious link to FA syndrome, a majority of the differentially expressed genes may be clustered into functional, tissular or cellular groups potentially related to FA phenotype. Interestingly, the specific changes in RNA expression observed suggest that FANCC regulates genes involved in myeloid differentiation and inflammatory response.
Results

Search for FANCC regulated genes
To investigate the transcriptional program under the control of FANCC activity, we compared RNA isolated from cells bearing two inactive FANCC alleles to that from their ectopically FANCC complemented counterpart. Exogenous expression of wild-type (wt) FANCC (HSC-536CORR cells) normalized FANCC protein expression, FANCD2 activation in response to MMC and the cellular and chromosomal sensitivity to MMC of the FA-C cells (HSC-536) (Figure 1 ).
To assess changes in RNA expression as a function of FANCC activity, we used RNA hybridization to Affymetrix microarrays that allows the monitoring of the expression of about 10 000 human genes and unnamed human ESTs.
A major difficulty in microarray comparison is the noise generated at multiple steps including biological sample collection, RNA extraction, chip manufacture, preparation of cRNA, hybridization and global normalization of signals between chips (Mills et al., 2001) . To limit noise, three different experiments following the plan depicted in Figure 2a were performed. For experiments I and II, a frozen tube of each cell line (corrected versus uncorrected FA-C cells) was thawed and cultured for 2 weeks before RNA extraction. For the first experiment, RNA was isolated from HSC-536CORR and HSC536Neo cells and stored. For the second experiment, HSC-536CORR was cultured 1 week more and RNA was extracted in parallel with that of the parental HSC-536 cell line and stored. The four extracted RNAs were processed contemporarily to be converted into 'targets' for hybridization to microarrays. A third experiment was performed to compare RNA extracted from HSC-536CORR to HSC-536Neo cells starting from cell cultures obtained from new thawed tubes of cells. The number of transcripts considered as expressed on each microarray was similar (Figure 2a) .
To evaluate technical and biological noise inherent to the microarray analysis in our experiments, we compared data from the three arrays hybridized with HSC-536CORR mRNA: (A) array 2-3, (B) array 2-5 and (C) array 3-5. Applying a threshold of twofold change in expression level between arrays, 134 genes were considered as differentially expressed in (A), 571 in (B) and 585 in (C). Since RNA was isolated from the same cell line, the observed differences are likely related to the biotechnical variability intrinsic to this approach. Indeed, analysis of the overlap among the three comparisons revealed that five sequences emerged as consistently differential (Figure 2b) . Consequently, 0.38% (5/1290) was the frequency of expected false-positive signals performing a triplicate experiment as presented.
Comparing FA-C to FA-C corrected cells, 687 sequences were detected as differentially expressed in the first experiment (Figure 2b , right diagram, array 2versus 1), 476 in the second experiment (Figure 2b , right diagram, array 3 versus 4) and 234 in the third experiment ( Figure 2b , right diagram, array 5 versus 6). Looking at the overlap between the three independent experiments, 49 sequences emerged as differentially expressed. This is significantly above what would be expected based on fluctuations due to technical and biological variability (6.4 sequences, i.e. 0.38% of the 1387 sequences). Among the 49 differentially expressed sequences, 40 genes were highly expressed in FA-C compared to FA-C corrected cells, that is, downregulated by the ectopical expression of wt FANCC (Table 1) .
Validation of differential expression profile
In all, 38 of the 49 sequences reported in Table 1 correspond to known genes. Interestingly, one of these, MxA, has been already identified as overexpressed in FA-C cells by other means (Li and Youssoufian, 1997) . Among the known genes, 10 sequences (30%) identified as overexpressed in FA-C cells and two (40%) identified as overexpressed in FANCC-corrected cells have been further examined for differential expression by semiquantitative RT-PCR analysis (Figure 3a) . To do this, we examined the RNA samples employed for microarray measurement and also RNA obtained from at least two other independent extractions. Actin was used as a standard. As seen in Figure 3a , a differential gene expression profile between FA-C and FA-C corrected cells was confirmed for all the analysed sequences by this approach.
The expression of four genes, vHNF1, MIC1, COX-2 and GCR-a, were analysed by real-time quantitative PCR. The expression of each target genes was normalized to 18S expression and is plotted in Figure 3b . Three analysed sequences are clearly overexpressed in FA-C cells compared to the corrected cell line. On the contrary, the expression of the GCR-a was not significantly different between FA and corrected cells.
To ensure that the differential intracellular level of RNA between FA-C and FA-C corrected cells correlates with full correction of the phenotype and is not an artifact due to the ectopic expression of wt FANCC, the expression of some of the genes founded previously as differentially expressed was compared by RT-PCR between FA-C, FA-C corrected and a normal cell line. As presented (Figure 4 ), the expression of the analysed genes is similar in HSC-536CORR and HSC-93 normal cells. These data suggest that the observed modifications in gene expression are due to the correction of the FANCC defect in FA-C cells and not an artifact of the transfection and selection process.
To further extend our observations, we quantified by real-time PCR the expression of some previously analysed genes in HSC-72 cell line, belonging to FA complementation group A, and in EU239L, another FA-C-derived cell line. As reported in Figure 5 , the expression of the analysed genes, normalized to 18S expression as internal standard, was higher in the two FA-derived cell lines than in normal cells. This suggests that the anomalies in gene expression observed by microarray in FA-C cells are not linked to the genetic background of the particular FA-C patient from which HSC-536 cell line was derived, but are a feature of FA syndrome.
MDR1 gene overexpression links to P-glycoprotein overactivity
MDR1 gene codes for a P-glycoprotein (P-gp) belonging to the ATP-binding cassette family of transporters that acts as a pump responsible for cellular efflux of both endogenous (steroid hormones, cytokines) or exogenous (chemical drugs) molecules (Lehnert, 1996; Dolis et al., 1997) . Moreover, it has been reported that P-gp plays a drug efflux-independent role associated to poor prognosis in AML (Pallis and Russell, 2000) . To analyse the biological implication of the overexpression of the MDR1 messager observed by microarray analysis in the absence of wt FANCC, we use a flow cytometry-specific approach to measure P-gp activity. Cells were loaded with rhodamine 123, and the intracellular level of the fluorescent molecule was monitored at time 0 (at the end of the 30 min loading) and after 3 or 6 h of culture in R123-free medium (efflux) ( Figure 6 ). The frequency of cells, which have eliminated the R123 accumulated intracellulary during the loading, is reported at the left of the dashed line in the plot. It is clear that R123 efflux was higher in FA cells from A and C complementation groups than in corrected or normal cells, suggesting a Figure 6 was carried out several times, given similar results. When the efflux of R123 was examined in the presence of the P-gp blocker cyclosporin A (CsA), a clear reduction was observed in FA cells, confirming that the higher R123 efflux in these cells is due to MDR1 overactivity.
A link between FA mutations and NF-kB activity
Several mRNA identified as overexpressed in FA-C cells are known to be upregulated during inflammation (see Discussion). A master regulator of the inflammatory response is the transcription factor NF-kB (Hanada and Yoshimura, 2002; Li and Verma, 2002; Ward and Lentsch, 2002) . Interestingly, previous work reported that NF-kB activity was more elevated in FA cells (Ruppitsch et al., 1997) . To test the potential involvement of NF-kB activity in the altered gene expression observed here, we treated FA-C cells with the NF-kB inhibitor curcumin and analysed by real-time RT-PCR the expression of COX-2 mRNA, a direct target of the transcriptional activity of NF-kB (Jobin et al., 1999; Zhang et al., 1999) . COX-2 expression, which is elevated in FA cells (Table 1) , was significantly reduced in cells treated with the NF-kB inhibitor (Figure 7b ). These data suggest that the loss of FA proteins could be responsible for an upregulation of the basal NF-kB transcriptional activity, and therefore of some of the genes regulated by this pathway.
Discussion
Using microarray analysis to decipher the transcriptional program related to FANCC activity, we have identified 33 known and seven unknown sequences whose expression was enforced in the absence of wt FANCC (Table 1a) . Only five known and four unknown sequences were turned on when FA-C cells were ectopically complemented (Table 1b) . To further strengthen our observations, the original data from microarray analysis were validated by alternative approaches in FA-C cells and extended to another FA complementation group. How informative is our information and does it open new research perspectives to a better understanding of the FA syndrome? In other words, two major questions arise from our observations: can these genes be clustered in genetically, functionally or pathologically defined groups? How may our data be integrated in the context of the FA clinical and cellular phenotype?
Microarray technology opened the possibility to scan simultaneously the expression of thousands of genes. Obviously, in spite of this power, the results will not be totally exhaustive. As reported in the results paragraph, biological and technical endpoints are per se an inevitable source of variability, which should be added to the criteria to decide when a gene is differentially expressed among two samples. For example, in a Mycoverexpressing engineered cell system, all the previously known targets of this transcription activator were not isolated by microarray analysis (Coller et al., 2000) . Moreover, as reported in Figure 2 , false positives can emerge from RNA compared at different moments from the same cells. For these reasons, samples should be analysed several times and from different extractions as we did in this work. Moreover, if the differential between two samples is low, that is around twofolds, it may be difficult to observe it constantly and it may be not confirmed by other approaches, as in the case of GCR-a. A consequence of these pitfalls is that the emergence of clusters of genes whose expression may correlate with a common biological endpoint represents FA is the most common inherited bone marrow failure syndrome. Pancytopenia, high incidence of AML and multiple congenital anomalies are associated with impaired hematopoiesis, arguing for an important role of the FA proteins in the differentiation and development process. Hematopoiesis is generally depicted as a hierarchical process (Orkin, 2000) . A complex network of signals drives the steps leading from the hematopoietic pluripotent stem cells to mature blood cells, a process that results in the expression of particular sets of genes at each step. RNA used in our analysis was obtained from a FA-C-derived EBV-transformed B-lymphoblastoid cell line. Strikingly, expression of several genes found regulated by FANCC is normally absent or low in lymphoblastoid cell lineages and rather expressed in liver, retina or myeloid cells. In the next paragraphs, the clustering of identified RNAs on the basis of tissular or functional characteristics is presented and discussed (Figure 8 ).
Genes expressed in myeloid cells
A first group, which includes HHEX, JAG1, FGFR1, SKAP55R and GA733-1, defines a class of genes involved in myeloid differentiation. HHEX is a divergent homeobox gene coding for a transcription factor activated during embryogenesis. In adults, its expression is maintained in hepatocytes and multipotent hematopoietic cells (Bedford et al., 1993; Hromas et al., 1993) . It has been proposed that its unscheduled activation contributes to leukemia, probably maintaining transformed cells in an undifferentiated state (Manfioletti Hansen and Justice, 1999) . JAG1, a membrane-bound ligand of the receptor Notch, is involved in fetal liver hematopoiesis and in adult erythropoiesis and granulopoiesis (Lindsell et al., 1995; Karanu et al., 2000; Walker et al., 2001) . Abnormalities in the Notch/Jagged signalling cause excessive cell selfrenewal, block or delay differentiation and are involved in AML (Tohda and Nara, 2001) cells in an undifferentiated status. Similarly, the constitutive activation of the transmembrane tyrosine kinase receptor FGFR1 was associated to both myelodysplasia and leukemia (Macdonald et al., 1995; Popovici et al., 1998 Popovici et al., , 1999 . Consequently, it may be proposed that the concomitant activation of HHEX, JAG1 and FGFR1 contributes to drive stem cells along the myeloid compartment and contemporarily to maintain cells in a preterminally differentiated status. In contrast, SKAPP55R and GA733-1 are normally highly expressed in myeloid lineages in association to advanced differentiation state (Hashimoto et al., 1999; Curtis et al., 2000) . Their overexpression in FA cells may balance or potentiate the action of HHEX, JAG1 and FGFR1. Indeed, ectopic expression of SKAPP55R inhibits growth of both myeloid and primary hematopoietic cells (Curtis et al., 2000) .
Genes expressed in liver and/or involved in cholesterol/bile acid metabolism vHNF1, CYP7B1, UGT2B7, ATPB1 and OAT can be clustered together because they are expressed mainly in the liver and involved in cholesterol/bile acid metabolism. Whether anomalies in the expression of these genes rely or not on alterations in this metabolic process in FA remains to be determined. However, it has to be noted that ectopic expression of OAT leads to disruption of mitochondria (Sullivan et al., 1996) . Interestingly, the mitochondria structure in FA cells presents several morphological unexplained anomalies (Rousset et al., 2002) . Like HHEX, vHNF1 is a homeotic transcription factor involved in embryogenesis and organogenesis and expressed in adults in epithelial cells of the liver, kidney, lung, pancreas and genital tract (Reber and Cereghini, 2001) . In Zebrafish embryogenesis, vHNF1 is necessary for HEX expression (Sun and Hopkins, 2001) . Moreover, vHNF1 and the related HNF1 protein, whose activity has been related to cholesterol/bile acid metabolism, bind as homo-or heterodimers to the same motif (Tronche and Yaniv, 1992) . This motif is present in CYP7B1 and UGT2B7 promoters. Thus, it is tempting to speculate that vHNF1 overexpression in the absence of wt FANCC is responsible for the high expression of its potential targets, HHEX, CYP7B1 and UGT2B7, observed in FA-C cells.
Genes involved in inflammation
A last group of RNAs highly expressed in FA-C cells includes genes normally turned on during inflammation. Inflammation is a biological process orchestrated mainly by myeloid cells and accompanied by modifications in cholesterol metabolism. Moreover, it has been previously demonstrated that one of the major proinflammatory cytokines, the TNF-a, is overexpressed in FA syndrome both in vitro and in vivo. Altogether, these observations are consistent with the existence of a proinflammatory status in FA syndrome. Our results presented here indicate that overexpression of genes involved in inflammation may be due to a constitutive activation of the major inflammatory transcription factor, NF-kB (Li and Verma, 2002; Hanada and Yoshimura, 2002; Ward and Lentsch, 2002) . Although the molecular basis of the connections between FA and overexpression of inflammatory genes and proteins remains to be clarified, the product of several genes of this cluster (Figure 8 ) might be particularly relevant beyond their role in inflammation with regard to FA characteristics.
Our data identified OAS and MxA genes as deregulated in the absence of wt FANCC. The products of these genes, together with PKR, constitute the main antiviral pathways induced by IFNs. It has been previously demonstrated that MxA is upregulated in the absence of FANCA, B, C or D1 proteins activity and that its ectopic overexpression leads to MMC hypersensitivity (Li and Youssoufian, 1997) . PKR anomalies have also been involved in FA (Pang et al., 2001b) . Our data are consistent with these observations pointing to a constitutive activation of the IFNsinduced signalling pathway in FA syndrome. Whether the activation of this particular antiviral pathway is associated to a constitutive overexpression of IFNs remains to be determined.
Among the other genes overexpressed in FA and clustered in the inflammatory group, IL-1RA, MIC-1 and HSP-70 may be related to the clinical and cellular characteristics of FA. Increased release of IL-1RA has been reported from AML blasts derived from patients classified as AML-M4 and AML-M5 subtypes (Schreuder et al., 1997) . Indeed, its overexpression in FA may be related to the myelodysplasic traits of the syndrome. MIC-1, a divergent member of the TGF-b superfamily, is activated by DNA damage or by proinflammatory cytokines (Li et al., 2000) . Its overexpression is consistent with FA bone marrow failure as it inhibits proliferation of primitive hematopoietic progenitors. Finally, we have also found that gene coding for HSP-70 is deregulated in FA-C cells. Expression of HSP-70 has been associated to DNA damage, oxidative stress and inflammation and increases the resistance of cells and tissue to damage. HSP-70 is one of the proteins isolated as FANCC interactor (Pang et al., 2001a) .
The other genes related to FANCC activity
Among the other genes isolated as overexpressed in the absence of wt FANCC, the two GTPase regulators, RPR3 and RhoE, CASK and PITSELRE B can be related to FA phenotype. CASK, RPR3 and RhoE might be involved in the cytoskeleton anomalies reported in FA, while PITSELRE B overexpression might be related to the G2 phase elongation that characterizes FA cells.
Few genes have been isolated as upregulated in FA-C corrected cells compared to the parental FA-C cells. A common trait of the majority of the product of these genes is their implication in growth control, a biological activity associated to terminal differentiation. This again emphasizes the role of FANCC as a mediator of differentiation.
Conclusion
In light of the clinical and cellular features of FA syndrome, understanding the genetic program regulated by FANCC is critical for elucidating molecular mechanisms involved in pathologies like aplastic anemia and cancer. Our approach has determined that genes involved in hematopoietic differentiation/development and inflammation are overexpressed in FA cells. On the basis of our data, it is tempting to speculate that a major function of the FA complex is to regulate expression of genes involved in myeloid differentiation and in inflammatory response. Interestingly, the activity of NF-kB, a major player involved in transcription regulation during differentiation and inflammation, appears to be increased in FA-derived cell lines (Ruppitsch et al., 1997) . The pharmacological inhibition of NF-kB activity results in downregulation of COX-2 expression, suggesting that the overexpression of some of the genes in FA could be directly related to NF-kB overactivation. At that stage, the mechanism of gene regulation by wt FANCC is not deciphered. However, it has been previously shown that wt FANCC physically interacts with a transcriptional repressor (Hoatlin et al., 1999) . Moreover, wt FANCA interacts with BRG1 and BRCA1 (Otsuki et al., 2001; Folias et al., 2002) , which both have a function as transcriptional coactivators. Of particular interest is the result of a recent paper showing that BRCA1 specifically increases NF-kB transcriptional activity (Benezra et al., 2003) . Our results show that the ectopic expression of FANCC in FA-C cells represses more genes than it induces (40vs9). Consequently, a general repressive action on transcription seems to be associated with the wt FANC protein activity.
In spite of the genetic instability and the DNA damage hypersensitivity of the syndrome, no gene coding for proteins directly involved in DNA repair/ damage response was found constitutively deregulated by our analysis. This observation suggests that FANCC does not control genes involved in DNA repair at the transcriptional level, but does not exclude a regulation at translational or post-translational level or by protein/ protein interactions. Further studies are needed to focus on the significance of the genes identified in our analysis during the natural history of the disease.
Materials and methods
Cell lines
EBV-transformed lymphoblasts from an FA-C complementation group patient and from an apparently healthy donor, HSC-536 and HSC-93, respectively, were kindly provided by M Buchwald (Hospital for Sick Children, Toronto, Ontario, Canada) (Strathdee et al., 1992) . HSC-536CORR is an HSC-536 derivative cell line infected with the wt FANCC cDNA inserted into the pAAV/Ad.psub201 plasmid as reported (Walsh et al., 1994) . HSC-536Neo is an FA-C cell line infected with the empty vector carrying the neomycin resistance gene. HSC-72 lymphoblasts derived from an FA-A complementation group patient and EU239L lymphoblasts belonging to an FA-C complementation group patient were kindly provided by M Buchwald and H Joenje (Vrije University, Amsterdam, The Netherlands), respectively. Cell lines were maintained in exponential growth in RPMI1640 medium (Life Technology, USA) supplemented with 12% fetal calf serum (Dutcher, France) by a daily dilution to 3 Â 10 5 cells/ml. HSC-536Neo and HSC-536CORR cells were grown in the presence of 200 mg/ml of G418 (Sigma, USA).
Measurement of mitomycin C (Sigma, USA) growth inhibition and chromosome breakage induction was performed as previously described (Rosselli et al., 1994) .
Analysis of the FANCC protein expression and FANCD2 activation by mitomycin C (100 ng/ml) was performed by standard Western blot using anti-FANCC and anti-FANCD2 antibodies (Santa Cruz Biotechnology, USA).
Total RNA extraction
Total cellular RNA was extracted from exponentially growing cells using the RNeasy kit (Qiagen, France) following the protocol described by the supplier with two rounds of 30 min of DNase (Qiagen, France) treatment.
Oligonucleotide array analysis of RNA samples
Total RNA (10 mg) from each sample were labelled and hybridized to the Human Genome U95v2 Gene Chip microarray according to the supplier's protocols (Affymetrix, USA).
A gene was considered as expressed if its probe set result was rated as present by the GeneChip software (MAS4.0, Affymetrix, USA). In the comparison between two chips, an RNA was considered differentially expressed when it was rated different (increased or decreased) by the GeneChip software and the fold change was at least equal to two.
Semiquantitative RT-PCR analysis
Total RNA (1 mg) was reverse transcribed from oligo-dT primers, and the resulting cDNA were amplified by PCR using gene-specific primers (Genset, France) designed with the Primer3 software. Primer sequences can be provided on request. PCR reactions were performed using the Ready-toGo PCR beads (Pharmacia, USA) following the instructions of the supplier. Each reaction was performed at 581C, and the number of cycles was adjusted for each targets. PCR products were separated on 2% agarose gel running in TAE 1 Â buffer and labelled with BET.
Real-time PCR amplification using taqman assay RNA was quantified by Agilent technology. Primers for amplifications were purchased from Perkin Elmer/Applied Biosystems (USA). Total RNA was reverse transcribed and real-time PCR was carried out on an ABI/Prism 7700 sequence detector system (TaqMan-PCR; Perkin -Elmer/Applied Biosystems, USA).
Rhodamine 123 efflux assay
Exponentially growing cells were incubated 30 min at 371C in the presence of 1 mM rhodamine 123 (R123) (Sigma, USA). At the end of the loading period, cells were pelleted and resuspended in warm complete culture medium in absence of R123. Aliquots of loaded cells were kept at 41C. The efflux of R123 was followed up to 6 h after the end of loading. In some experiments, cells were resuspended in complete medium containing 100 mM of the P-gp blocker cyclosporin A (Sigma, USA). All samples were kept at 41C until cytometric analysis was performed. Fluorescence of R123 was analysed on a FACScalibur flow cytometer and processed by Cell Quest Software (Becton-Dickinson, USA).
